Registry for first-time ablation of atrial fibrillation
First-time Ablation of Atrial Fibrillation Registry
This study looks at what factors can help doctors choose the right patients for their first ablation treatment for atrial fibrillation to make the procedure more successful and safer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medical University of Warsaw Academic / other |
| Locations | 1 site (Warsaw) |
| Trial ID | NCT06381245 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify predictors of successful ablation in patients with atrial fibrillation (AF) by examining various clinical, electrophysiological, electrocardiographic, ultrasound, cardiac anatomy, and biomarker factors. The goal is to analyze these predictors to improve patient selection for ablation procedures, thereby increasing success rates and minimizing unnecessary risks. By tailoring therapeutic decisions based on individual patient profiles, the study seeks to enhance the overall management of AF.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals with paroxysmal or persistent atrial fibrillation who are undergoing their first ablation.
Not a fit: Patients who are unable to give informed consent or have serious health conditions existing prior to ablation may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved outcomes for patients undergoing ablation for atrial fibrillation by identifying the best predictors for treatment success.
How similar studies have performed: While there have been studies on predictors of ablation success, this specific approach focusing on a comprehensive set of factors is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * paroxysmal or persistent AF * first-time ablation of AF Exclusion Criteria: * patients unable to give informed consent * serious health condition existing before ablation
Where this trial is running
Warsaw
- Medical University of Warsaw — Warsaw, Poland (Recruiting)
Study contacts
- Principal investigator: Monika Gawałko, MD, PhD — 1st Department of Cardiology, Medical University of Warsaw
- Study coordinator: Monika Gawałko, MD, PhD
- Email: monika.gawalko@wum.edu.pl
- Phone: 22 599 19 58
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.